The University of Nevada, Reno School of Medicine

CME Satellite Symposium Path to Relief Advancing Care in Atopic Dermatitis With JAK Inhibitors V5

MD, PhD

Discuss strategies for effective clinical management of patients with atopic dermatitis (AD) inadequately controlled with biologic treatment 

Identify patients with moderate-to-severe AD for systemic therapy with Janus kinase (JAK) inhibitors 

Select the appropriate dose of JAK inhibitors to optimize treatment of AD

large_image (2).png

medium_image (2).png

small_image (2).png

thumbnail_image (2).png

image (2).png

Atopic Dermatitis

On-Demand CME Videos

WCM25: Path to Relief: Advancing Care in Atopic Dermatitis With JAK Inhibitors: An Online Activity

JAK Inhibitors

derm2derm

Acne

Aesthetics

Alopecia

Actinic Keratoses

Melanoma

Warts

Psoriasis

Psoriatic Arthritis

Rosacea

Skin Cancer

Vitiligo

View All

Conditions

CME & Education

Conferences

News

Videos

Podcasts

Cases

Content

DermToolkit

Journals

Job Board

PA & NP

Early Career

Weekly Competitions

Patient First Communication

Membership

Quick Reference Charts

Discount Pharmacies

Resources

PA/NP

Early-Career

Access Management

Career Services

Patient-First Communication

Practice Management

CME Mission

Our Accreditation Partners

Our Purpose

Our Faculty

Our Offerings

Contact Us

About

WCM25: Path to Relief: Advancing Care in Atopic Dermatitis With JAK Inhibitors: An Online Activity

About

Availability

Learning Objectives

Intended Audience

Faculty

Accreditation Statement

Credit Designation Statement

Disclosures